Chemicals and pharmaceuticals · BTAI

BioXcel Therapeutics, Inc.

12 filings mentioning 2 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
2topics disclosed
Chemicals and pharmaceuticalsindustry
CTbased in

Across 12 filings we hold, BioXcel Therapeutics, Inc. has written down 2 of the topics we track. That places it 32 of 518 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

TopicFilingsMost recent
Artificial Intelligence482026-05-15
Business Continuity12023-11-14

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-05-158-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2026-03-278-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-11-128-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-08-128-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-08-118-KRegulation FD disclosure, Financial statements and exhibitsfiling
2025-05-128-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-03-278-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-11-148-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-08-068-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-07-168-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-05-098-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-04-228-KRegulation FD disclosure, Other material event, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
FIBROGEN INC12compare →
PALATIN TECHNOLOGIES INC12compare →
MATEON THERAPEUTICS INC12compare →
Enveric Biosciences, Inc.12compare →
Sarepta Therapeutics, Inc.12compare →
REGENERON PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition